ACW.AX

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2027	$39M	+249.7%	$-0.00	$-0.00–$-0.00	—	1
2028	$0	-100.0%	$-0.01	$-0.01–$-0.01	—	1
2029	$0	—	$-0.02	$-0.02–$-0.02	—	1
2030	$77M	—	$-0.00	$-0.00–$-0.00	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$0.01

Price

$0.06

Implied downside

-89%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ACW.AXActinogen Medical Limited	$0.06	-5.00%	$212M	—
ALA.AXArovella Therapeutics Limited	$0.06	-1.67%	$71M	—
ATH.AXAlterity Therapeutics Limited	$0.42	-5.56%	$92M	—
BIO.AXBiome Australia Limited	$0.37	+4.23%	$84M	—
EZZ.AXEZZ Life Science Holdings Limited	$0.43

Actinogen Medical Limited

Actinogen Medical Limited is an Australian biotechnology company dedicated to developing treatments for neurological and neuropsychiatric disorders linked to imbalanced brain cortisol levels. Their lead product, Xanamem, an inhibitor of the 11ß-HSD1 enzyme, is currently in Phase 2 clinical trials. This compound has demonstrated target engagement within the central nervous system and is being investigated for its potential in conditions such as Alzheimer's disease, depression with cognitive impairment, and the anxiety, sleep, and behavioral issues associated with fragile X syndrome. Founded in 1999, the company was formerly known as Actinogen Limited, adopting its current name in November 2015, and is headquartered in Sydney, Australia.

www.actinogen.com.au

Employees: 6
IPO / List date: Oct 16, 2007
HQ: AU

Held by traders on TradeandTell

No one on the platform currently holds ACW.AX.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ACW.AX as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ACW.AX yet.